The look also provided an evaluation from the acute and chronic toxicities from tipifarnib to placebo and assessed standard of living (QOL) on both arms
The look also provided an evaluation from the acute and chronic toxicities from tipifarnib to placebo and assessed standard of living (QOL) on both arms. principal endpoint, as well as the trial was driven to identify whether tipifarnib doubled TTP weighed against placebo. Toxicity, response, and standard of living were supervised. Results Sixty-two sufferers were…